-
Drug Farm’s DF-003 Earns FDA Rare Pediatric Disease Designation for ROSAH Syndrome
•
Sino-US biotech company Drug Farm has announced that it has received Rare Pediatric Disease Designation (RPDD) from the US Food and Drug Administration (FDA) for its first-in-class drug candidate DF-003, which is being investigated as a potential treatment for the ROSAH (retinal malnutrition, optic edema, splenomegaly, anhidrosis, and headache) syndrome.…
